The Global GERD Drugs and Devices market Report offers extensive knowledge and information about the GERD Drugs and Devices market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global GERD Drugs and Devices market further validated and verified by the industry experts and professionals. The Global GERD Drugs and Devices Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the GERD Drugs and Devices market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market.
Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/383
The expiration of the patent on most of the drugs is paving the way for new over the counter and generic drugs. The poor reimbursement of procedures and devices, low safety, and efficacy are restricting the adoption of the GERD drugs and devices market.
The MUSE or Medigus Ultrasonic Surgical Endostapler is an extensive endoscopic device that incorporates the latest technological advancement for the delivery of patient-friendly option for Transoral Fundoplication, the procedure intended for the treatment of GERD.
North America held the largest share, with the U.S. contributing the major revenue share. The rise in the geriatric population in the region, which is prone to acid reflux and development in heartburn, will drive the demand of the Gastroesophageal Reflux Disease Drugs and Devices market
Key participants include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.
The global GERD Drugs and Devices market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the GERD Drugs and Devices sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.
Regional Analysis of the GERD Drugs and Devices Market:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report: https://www.emergenresearch.com/request-for-customization/383
Rapid Business Growth Factors
In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor that’s helping the market grow faster than usual is the tough competition.
Let us know if you have any specific requirements. We offer report customization.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.
For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:
Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
Drug Type Outlook (Revenue, USD Billion; 2017-2027)
H2 Receptor Antagonist
Proton Pump Inhibitor (PPIs)
Device Type Outlook (Revenue, USD Billion; 2017-2027)
MUSE –Medigus Ultrasonic Surgical Endostapler
LINX Management System
Bravo Reflux Testing System
Digitrapper reflux testing system
Key Points of GERD Drugs and Devices Market:
Extensive coverage of the analysis of the GERD Drugs and Devices market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the GERD Drugs and Devices market
Complete data about the key manufacturers and vendors in the GERD Drugs and Devices market
Read More: https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs